A new “biochip” under development to accurately identify disease strains may reduce costs for medical testing and also reduce wait time for results. The Hydra-1K—which is a silicon chip—can be used at ...
LONDON--(BUSINESS WIRE)--The biochip market is expected to grow by USD 19.71 billion, progressing at a CAGR of almost 22% during the forecast period. Get a Free Sample Report Delivered Instantly to ...
In recent years, the measurement of multiple proteins as disease signatures or biomarkers from patient samples has risen rapidly as an enabling tool for the pharmaceutical and diagnostics industries.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results